|
Friday, November 22, 2019
Print Current Session:
 |
|
|
Friday
SESSION 85:
IMPORTANT NEW DEVELOPMENTS IN MEDICAL AND ANTI-ATHEROGENIC AND ANTICOAGULANT DRUG TREATMENTS; UPDATES ON UNUSUAL DISEASES AND THEIR INTERVENTIONAL VASCULAR TREATMENT; MANAGEMENT OF TAVR ARTERIAL ACCESS COMPLICATIONS
|
|
| SESSION 85 SCHEDULE | |
| 2:34 PM - 2:39 PM | Statin Intolerance In Vascular Patients: Incidence, Management Techniques And Their Outcomes: From The VQI |
|
Presenter(s):Adam Beck, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 2:40 PM - 2:45 PM | Optimal Current Antiplatelet Treatment In Patients With Vascular Disease And After Interventional Or Open Treatment: When Is Aspirin Indicated And When Not |
|
Presenter(s):Roxana Mehran, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 2:46 PM - 2:51 PM | Value Of Protamine Use With Transfemoral CAS, TCAR And CEA: It Decreases Strokes And Postprocedural Bleeding |
|
Presenter(s):Marc L. Schermerhorn, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 2:52 PM - 2:57 PM | Why Clopidogrel Testing Is Important In CAS Trials And Other Vascular Trials |
|
Presenter(s):Karthikeshwar Kasirajan, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 2:58 PM - 3:03 PM | Why Vascular Surgeons And Specialists Should Replace Heparin With Bivalirudin For Vascular Interventions |
|
Presenter(s):George H. Meier, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 3:04 PM - 3:09 PM | Newer Oral Anticoagulants Are Not Helpful In Improving Outcomes After Lower Extremity Bypasses: However, Warfarin Is Helpful: What Is The Evidence |
|
Presenter(s):William P. Robinson, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 3:10 PM - 3:15 PM | Why EVAR Patients Must Be Given Statins Or Have Their Statin Dose Increased Perioperatively: Cardiac Complications Are The Main Cause Of Complications And Readmissions And Statins Decrease These |
|
Presenter(s):Bruce A. Perler, MD, MBA Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 3:16 PM - 3:22 PM | Panel Discussion |
| Moderator(s): Ronald M. Fairman, MD / Roxana Mehran, MD | |
| 3:22 PM - 3:32 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| UPDATE ON ENDOVASCULAR TREATMENT OF MULTIPLE SCLEROSIS AND OTHER HOT TOPICS | |
| 3:32 PM - 3:37 PM | Is There Any Hope That There Will Be Evidence To Support The Value Of Venous Angioplasty To Treat Multiple Sclerosis – Despite Negative Level 1 Evidence |
|
Presenter(s):Paolo Zamboni, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 3:38 PM - 3:43 PM | What Is The Evidence That Venous Obstruction Contributes To Multiple Sclerosis And That Relieving This Obstruction Can Help Some Patients: Which Patients And How To Select Them |
|
Presenter(s):Donald B. Reid, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 3:44 PM - 3:49 PM | Biomarkers Can Predict Poor Outcomes Of Vascular Surgery: Which Biomarkers; Which Procedures |
|
Presenter(s):Todd R. Vogel, MD, MPH Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 3:50 PM - 3:55 PM | Natural History Of Penetrating Ulcers Of The Abdominal Aorta: How Should They Be Treated |
|
Presenter(s):Caron B. Rockman, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 3:56 PM - 4:01 PM | Natural History Of Common Iliac And Internal Iliac Artery Aneurysms: They Are Benign When ≤ 4 cm And Do Not Require Treatment Until >4 cm |
|
Presenter(s):Nicos Labropoulos, BSc (Med), PhD, DIC, RVT Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 4:02 PM - 4:07 PM | Current Endovascular Treatment Of Buerger’s Disease: What Is Possible And What Is Not |
|
Presenter(s):Kamphol Laohapensang, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 4:08 PM - 4:13 PM | Vascular Complications Of TAVR And How Are They Best Managed |
|
Presenter(s):Ashraf Mansour, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 4:14 PM - 4:20 PM | Panel Discussion |
| END OF SESSION 85 | |
| previous | next |